ArticleInternational journal of clinical pharmacy2026
Exploring hospital pharmacist perspectives on ethical considerations from automated patient prioritisation: a qualitative study.
Article in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe use of Hospital Electronic Prescribing and Medicines Administration (HEPMA) data in automated patient prioritisation (APP) tools is an emerging area of interest within pharmacy practice and research. As the Scottish Government continues to invest in digital transformation across health and social care, pharmacy professionals are increasingly required to adapt to new technologies whilst maintaining high standards of patient care. APP tools offer the potential to enhance operational efficiency and support clinical decision making. However, despite growing implementation internationally, there is a scarcity of published research exploring the ethical considerations associated with use.
aimTo explore hospital pharmacists' perspectives of ethical considerations from APP tool use prior to adoption in the hospital pharmacy setting.
methodTwo focus groups were conducted with a total of 12 hospital pharmacists (Pharmacist Team Manager n = 2, Advanced Pharmacist n = 5, Specialist Pharmacist n = 3, Pharmacist n = 2) from a Scottish Health Board prior to the implementation of APP using the 'CoRE-Values' ethical decision-making framework, with the aid of a clinical vignette for context. Focus group transcripts were analysed thematically with the four domains of the framework as mapped themes.
resultsParticipants considered the use of APP to be a fair and pragmatic approach to managing daily workload, enabling pharmacy teams to focus on patients most at risk of medication related harm. However, professional judgement remains essential when interpreting APP outputs, and caution must be exercised to avoid an overreliance on automation. The clinical rules underpinning APP must be regularly reviewed to ensure alignment with current practice and emerging evidence. While complete visibility of high-risk patients offers significant clinical value, it may also expose limitations in workforce capacity. Participants noted that this visibility could be leveraged to support business case development to secure further staff resource and/or service transformation.
conclusionAPP use can support clinical decision making by directing pharmacy staff to patients at risk of medication related harm in hospitals, but ethical concerns can arise if organisations do not give due consideration to these issues prior to adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.